Assessing Unique Risk Factors for COVID-19 Complications Among Cancer Patients: A Multi-ethnic Cohort Study

Hala T. Borno, Mi‐Ok Kim, Irina Tolstykh, Amy Lin, Julian C. Hong, Sasha Yousefi, Sylvia Zhang, Rana R. McKay, Olivier Harismendy, Pedram Razavi, Pelin Cinar, Hope S. Rugo, Vadim S. Koshkin, Maya Rabow, Christine Wang, Adina Bailey, Eric J. SmallJournal of Immigrant and Minority Health 2022 · DOI

TL;DR

This multi-institutional study investigated risk factors for COVID-19 complications in cancer patients, revealing that Hispanic ethnicity, male sex, and specific cancer types (malignant hematologic) are associated with increased risks of complications like sepsis and cardiac issues. The findings highlight the need for targeted mitigation strategies for vulnerable cancer patient populations, particularly minority groups.

What Problem Does This Paper Address?

The COVID-19 pandemic has disproportionately affected racial and ethnic minorities. While this trend is observed in the general population, understanding the specific risk factors for severe COVID-19 outcomes among cancer patients, who are inherently more vulnerable due to their disease and treatments, remains limited, especially across diverse ethnic groups. This paper aims to fill this gap by identifying unique demographic and clinical predictors of COVID-19 complications in a multi-ethnic cohort of cancer patients.

Methods

The researchers conducted a multi-institutional, multi-ethnic cohort study. They identified patients with an invasive cancer diagnosis and a confirmed SARS-CoV-2 infection between March and November 2020. Demographic and clinical data were manually collected from electronic health records and stored in a REDCap database. The primary analytical approach was multivariate logistic regression to assess the impact of various factors on COVID-19 complications. The study defined four primary endpoints: any complication, sepsis, pulmonary complications, and cardiac complications.

Datasets

The study utilized data from 303 cancer patients diagnosed with invasive cancer and confirmed SARS-CoV-2 infection, collected from the University of California San Francisco (UCSF) and the University of California San Diego (UCSD) between March and November 2020. This data was manually extracted from electronic health records. No new benchmarks were introduced; the study focused on analyzing existing patient data.

Key Insights and Ideas

  • Ethnic Disparities Persist in Cancer Patients: The study confirms that racial and ethnic disparities in COVID-19 outcomes extend to cancer patients, with Hispanic patients showing a significantly higher risk of developing any complication.
  • Sex Matters for Sepsis and Cardiac Issues: Male cancer patients were found to have a notably higher risk of sepsis and cardiac complications following COVID-19 infection.
  • Hematologic Cancers Pose Unique Risks: Patients with malignant hematologic cancers faced a significantly higher risk of developing sepsis compared to those with solid tumors.
  • Clinical Symptoms as Predictors: The presence of fever and cough, along with having two or more co-morbidities, were independently associated with an increased likelihood of experiencing COVID-19 complications.
  • Multimorbidity Amplifies Risk: Having multiple co-morbidities was a strong predictor not only of general complications but also specifically of sepsis and pulmonary complications.

Key Results

  • Hispanic/Latinx patients had a 2.31 times higher odds of experiencing any COVID-19 complication (OR 2.31, 95% CI 1.18–4.51).
  • Male patients had a 4.42 times higher odds of sepsis (OR 4.42, 95% CI 1.63–11.96) and a 2.02 times higher odds of cardiac complications (OR 2.02, 95% CI 1.05–3.89).
  • Malignant hematologic cancers were associated with a 3.93 times higher odds of sepsis (OR 3.93, 95% CI 1.58–9.81).
  • "Other" race/ethnicity (non-Hispanic and non-white) was associated with a 2.41 times higher odds of cardiac complications (OR 2.41, 95% CI 1.01–5.73).
  • Fever was independently associated with a higher odds of any complication (OR 1.88, 95% CI 1.05–3.39).
  • Cough was independently associated with a higher odds of any complication (OR 2.71, 95% CI 1.48–4.96).
  • Having ≥2 co-morbidities was significantly associated with any complication (OR 1.80, 95% CI 1.00–3.26), sepsis (OR 4.16, 95% CI 1.24–13.96), and pulmonary complications (OR 2.48, 95% CI 1.27–4.84).

Limitations and Future Work

The authors acknowledge several limitations:

  • Retrospective Nature: The study design is retrospective, which can introduce biases.
  • Limited Sample Size: The cohort of 303 patients is relatively small, potentially limiting the power to detect smaller effects or conduct more granular analyses.
  • Broad Cancer Grouping: Tumor types were broadly categorized into "solid" or "malignant hematologic," preventing the identification of unique risk factors specific to individual cancer types.
  • Short Follow-up: The study did not evaluate long-term complications of COVID-19 among cancer patients.

Future research directions suggested include:

  • Evaluating risk factors by specific tumor types.
  • Investigating long-term complications of COVID-19 in cancer patients.
  • Further analysis with larger sample sizes to examine associations more deeply, particularly regarding sex-based differences in sepsis outcomes.
  • Developing and testing targeted mitigation strategies for vulnerable populations, especially minority groups.

Summary updated

Abstract

A myriad of organ-specific complications have been observed with COVID-19. While racial/ethnic minorities have been disproportionately burdened by this disease, our understanding of the unique risk factors for complications among a diverse population of cancer patients remains limited. This is a multi-institutional, multi-ethnic cohort study evaluating COVID-19 complications among cancer patients. Patients with an invasive cancer diagnosis and confirmed SARS-CoV-2 infection were identified from March to November 2020. Demographic and clinical data were obtained and a multivariate logistic regression was employed to evaluate the impact of demographic and clinical factors on COVID-19 complications. The study endpoints were evaluated independently and included any complication, sepsis, pulmonary complications and cardiac complications. A total of 303 patients were evaluated, of whom 48% were male, 79% had solid tumors, and 42% were Hispanic/Latinx (Hispanic). Malignant hematologic cancers were associated with a higher risk of sepsis (OR 3.93 (95% CI 1.58-9.81)). Male patients had a higher risk of sepsis (OR 4.42 (95% CI 1.63-11.96)) and cardiac complications (OR 2.02 (95% CI 1.05-3.89)). Hispanic patients had a higher odds of any complication (OR 2.31 (95% CI 1.18-4.51)) and other race was associated with a higher odds of cardiac complications (OR 2.41 (95% CI 1.01-5.73)). Clinically, fever, cough, and ≥2 co-morbidities were independently significantly associated with any complication. This analysis evaluated covariates that can significantly predict a myriad of complications among a multi-ethnic cohort of cancer patients. The conclusions drawn from this analysis elucidate a mechanistic understanding of differential illness severity from COVID-19.
BibTeX
@article{borno2022assessing,
  author = {Hala T. Borno and Mi‐Ok Kim and Irina Tolstykh and Amy Lin and Julian C. Hong and Sasha Yousefi and Sylvia Zhang and Rana R. McKay and Olivier Harismendy and Pedram Razavi and Pelin Cinar and Hope S. Rugo and Vadim S. Koshkin and Maya Rabow and Christine Wang and Adina Bailey and Eric J. Small},
  title = {{Assessing Unique Risk Factors for COVID-19 Complications Among Cancer Patients: A Multi-ethnic Cohort Study}},
  journal = {Journal of Immigrant and Minority Health},
  year = {2022},
  doi = {10.1007/s10903-022-01413-w},
}
Figure